Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Barry L, Myones"'
Autor:
Jeffrey Chaitow, Terri H. Lipman, Fabrizio De Benedetti, Ricardo Machado Xavier, Hermine I. Brunner, James Frane, Jianmei Wang, Nicolino Ruperto, Roger C. Allen, Graciela Espada, Manuela Pardeo, Rayfel Schneider, Diane E. Brown, Alberto Martini, Kamal N. Bharucha, Barry L. Myones, Valeria Gerloni, Daniel J. Lovell
Publikováno v:
Arthritis & Rheumatology. 67:840-848
Objective To investigate the impact of tocilizumab treatment on growth and growth-related laboratory parameters in patients with systemic juvenile idiopathic arthritis (JIA) enrolled in a phase III clinical trial. Methods Patients with systemic JIA a
Autor:
Gili Kenet, Arzu Soybilgic, Laura Andreoli, Tadej Avcin, E. Ann Yeh, Barry L. Myones, M. Patricia Massicotte, Cassyanne L. Aguiar
Publikováno v:
Antiphospholipid Syndrome ISBN: 9783319554402
In preparation to the 15th International Congress on Antiphospholipid Antibodies (aPL), a multidisciplinary pediatric antiphospholipid syndrome (APS) task force was created in order to review the accumulated knowledge of the pediatric APS (pathogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5753a563cf59324d893d48f09bfc507
https://doi.org/10.1007/978-3-319-55442-6_16
https://doi.org/10.1007/978-3-319-55442-6_16
Publikováno v:
Congenital Heart Disease. 7:336-343
Objective. The objective of this study is to characterize variability in the acute management of Kawasaki disease and compliance of echocardiogram surveillance with published American Heart Association recommendations. Design. Retrospective review. S
Publikováno v:
American Journal of Clinical Pathology. 135:406-416
Severe manifestations of systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), and thrombotic thrombocytopenic purpura (TTP) are characterized by multiorgan thrombotic microangiopathy. We describe reduction of ADAMTS13 activity and the
Autor:
Robin L. Brey, Marietta M. de Guzman, Elfrides Traipe, Eyal Muscal, Barry L. Myones, Jill V. Hunter
Publikováno v:
The Journal of Rheumatology. 37:1768-1775
Objective.Cerebral atrophy is a prominent feature in adults with systemic lupus erythematosus (SLE). We assessed cerebral and cerebellar volume loss on clinically acquired brain magnetic resonance imaging (MRI) scans of children and adolescents with
Autor:
Barry L. Myones, Elfrides Traipe, Robin L. Brey, Jill V. Hunter, Eyal Muscal, Marietta M. de Guzman
Publikováno v:
Pediatric Radiology. 40:1241-1245
Endothelial damage, hypertension and cytotoxic medications may serve as risk factors for the posterior reversible encephalopathy syndrome (PRES) in systemic lupus erythematosus. There have been few case reports of these findings in pediatric lupus pa
Autor:
Imelda Victoria Cabalar, Peter A. Lachenbruch, Robert M. Rennebohm, Jason B. Monroe, Barry L. Myones, Ann M. Reed, Lauren M. Pachman, Lisa G. Rider, Maria L. Villalba, Brian M. Feldman, Frederick W. Miller, Angelo Ravelli
Publikováno v:
Arthritis & Rheumatism. 60:3425-3435
Objective We undertook this study to validate the Myositis Damage Index (MDI) in juvenile and adult myositis, to describe the degree and types of damage and to develop predictors of damage. Methods Retrospective MDI evaluations and prospective assess
Autor:
Raphael Hirsh, Aisha Ali, Susanne M. Benseler, Robert P. Sundel, Karen Watanabe Duffy, Elizabeth A. Shaw, Jane L. Park, Ciarán M. Duffy, Rosie Scuccimarri, Peter Chira, Laura E. Schanberg, Melissa M. Hazen, Christi J. Inman, Deborah Bork, Amy Woodward, Suzanne E. Ramsey, Elizabeth B. Brooks, Yukiko Kimura, Dawn M. Wahezi, Jennifer Frankovich, Kristin Houghton, Andrew Zeft, Dana Gerstbacher, Robert C. Fuhlbrigge, James N. Jarvis, Susan H. Ballinger, Candido Batres, Suzanne C. Li, Bracha Shaham, Anne M. Stevens, Jennifer Turner, Deborah McCurdy, Esi Morgan DeWitt, Ana Cabrera, Margalit Rosenkrank, Reuven Bromberg, Lisa Imundo, John Bonsack, Andrea Hudgins, David A. Cabral, A. Grom, Kenneth N. Schikler, Lorien Nassi, Sarah Ringold, Bianca A. Lang, Daniel J. Kingsbury, Aleasha Warner, Rhonda Wilder, Michael Henrickson, Fatma Dedeoglu, Gaëlle Chédeville, Troy R. Torgerson, Suzanne L. Bowyer, Mary Beth F. Son, Marilynn Punaro, Daniel Kietz, Diane E. Brown, Imelda Balboni, Helen Emery, Sarah Halford, Michal Cidon, Marisa S. Klein-Gitelman, Tzielan Lee, Steven J. Spalding, Anne Eberhard, Anne Johnson, Leslie Abramson, Adrienne Michels, Kristin Hayward, Paul Rosen, Michele Gibbon, Thomas G. Mason, Andreas Reiff, Peter N. Malleson, Lauren M. Pachman, Deborah M. Levy, Victor Espinosa, Kathleen A. Haines, Christy Sandborg, Carol A. Wallace, Adam M. Huber, Hermine I. Brunner, Lori B. Tucker, Steven J. Song, Philip J. Hashkes, S Prahalad, Stacy P. Ardoin, Thomas A. Griffin, Elizabeth Stringer, Virginia Pascual, Gloria C. Higgins, América G. Uribe, Jennifer Wargula, Stuart E. Turvey, Kathleen M. O'Neil, Jaime Guzman, Andrew H. Eichenfield, Thaschawee Arkachaisri, Norman T. Ilowite, Sarah Campillo, Ann M. Reed, Aimee O. Hersh, J Weiss, Susan Kim, Barry L. Myones, Mary Lesko, Emily von Scheven, Joyce J. Hsu, Nora G. Singer, Eyal Muscal, Thomas Klausmeier, Daniel J. Lovell, Egla Rabinovich, Kathryn S. Torok, Ross E. Petty
Publikováno v:
Arthritis & Rheumatism. 60:3413-3424
Objective To compare the criteria for Wegener's granulomatosis (WG) of the American College of Rheumatology (ACR) with those of the European League Against Rheumatism/Pediatric Rheumatology European Society (EULAR/PRES) in a cohort of children with W
Autor:
Ankur A Kamdar, Barry L. Myones, Arundhati S. Kale, Marietta De Guzman, M. John Hicks, Robert W. Warren, Anna Minta, María Honrubia Pérez, David J. Askenazi
Publikováno v:
Pediatric Nephrology. 22:981-986
Outcomes in children with proliferate lupus nephritis (PLN) show 9-15% progress to end-stage renal disease (ESRD) at 5 years. Immunosuppression improves outcome, but significant side effects are possible. Clinical and laboratory analyses are poor pre
Publikováno v:
Current Rheumatology Reports. 17
Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk